← Leaderboards
Kristopher Paolino
Icon Government And Public Health Solutions, Inc.
$4,299,774
Attributed
$4,299,774
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.1M · FY2018–21$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
Funding mix
By agency
NIH$4,299,774 · 1
By mechanism
N01$4,299,774 · 1
Top collaborators
No co-investigators on record.
Most similar at Icon Government And Public Health Solutions, Inc.
Same institution · by research overlap
- Robert Spitz$3,033,881
- J. McLeod Griffiss$3,088,882
- Robert Tibbetts$231,167
- Chris Mason$321,691
- Rob Tibbetts$113,678
Others in their field
Other Emerging Leaders on “Therapeutic Evaluation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Beth Baseler · Leidos Biomedical Research, Inc.$155,412,903
- Kimberly Smith · Ppd Development Lp$115,671,664
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
Research focus
Therapeutic EvaluationTherapeutic AgentsClinical Trials UnitImmunomodulatorsInfectious Disease TreatmentInvestigationNovel TherapeuticsPhase I Clinical TrialsCoccidioides ImmitisPneumocystis
Grant awards (4)
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR COCCIDIOIDES IMMITIS$30,000
N01 · FY2021 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS$1,185,838
N01 · FY2020 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR PNEUMOCYSTIS$1,642,152
N01 · FY2018 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF THERAPEUTICS FOR COCCIDIOIDES IMMITIS$1,441,784
N01 · FY2018 · AI · contact PI